相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study
Alicia Gilsenan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 30, pg 3, 2019)
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2020)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS—2020 UPDATE
Pauline M. Camacho et al.
Endocrine Practice (2020)
The Association between Serum Uric Acid and Bone Mineral Density in Older Adults
Xiaocong Yao et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
Richard Eastell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
The Paradoxical Role of Uric Acid in Osteoporosis
Kun-Mo Lin et al.
NUTRIENTS (2019)
Review of the Literature Examining the Association of Serum Uric Acid with Osteoporosis and Mechanistic Insights into Its Effect on Bone Metabolism
Neelam Kaushal et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2019)
The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment
Nuria Guanabens et al.
ENDOCRINE (2019)
Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis
Athanasios D. Anastasilakis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Effects of bone remodeling agents following teriparatide treatment
D. Burkard et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population
Dan-dan Yan et al.
ACTA PHARMACOLOGICA SINICA (2018)
Efficacy of Switching From Teriparatide to Bisphosphonate or Denosumab: A Prospective, Randomized, Open-Label Trial
Rui Niimi et al.
JBMR PLUS (2018)
The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis
Kosuke Ebina et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2017)
Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population
Wen Han et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study
J. N. Tsai et al.
BONE (2017)
The Influence of Serum Uric Acid on Bone Mineral Density, Hip Geometry, and Fracture Risk: The Rotterdam Study
Taulant Muka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
Benjamin Z. Leder et al.
LANCET (2015)
PINP as a biological response marker during teriparatide treatment for osteoporosis
J. H. Krege et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Executive Summary of the 2013 International Society for Clinical Densitometry Position Development Conference on Bone Densitometry
John T. Schousboe et al.
JOURNAL OF CLINICAL DENSITOMETRY (2013)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Safety of Osteoanabolic Therapy: A Decade of Experience
Cristiana Capriani et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary
Hajime Orimo et al.
Archives of Osteoporosis (2012)
Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
A. Blumsohn et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate
D. L. Kendler et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
S. Vasikaran et al.
OSTEOPOROSIS INTERNATIONAL (2011)
The diagnosis of osteoporosis
John A. Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Rapid and robust response of biochemical markers of bone formation to teriparatide therapy
Sarah J. Glover et al.
BONE (2009)
Prediction of Changes in Bone Mineral Density in Postmenopausal Women Treated with Once-Weekly Bisphosphonates
Sherri-Ann M. Burnett-Bowie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis
Steven Boonen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
Michael McClung et al.
BONE (2007)
Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis
DC Bauer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: The fracture intervention trial
DC Bauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis
DM Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass
MR McClung et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis
PQ Chen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis
R Lindsay et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Monitoring osteoporosis therapy with bone densitometry - Misleading changes and regression to the man
SR Cummings et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
